Published in Autoimmun Rev on May 10, 2010
Novel aspects of Sjögren's syndrome in 2012. BMC Med (2013) 1.44
Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol (2011) 1.17
Deimination of linker histones links neutrophil extracellular trap release with autoantibodies in systemic autoimmunity. FASEB J (2014) 0.92
To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice. J Autoimmun (2011) 0.86
Expression of IL-17, IL-23 and their receptors in minor salivary glands of patients with primary Sjögren's syndrome. Clin Dev Immunol (2012) 0.84
Serologic features of primary Sjögren's syndrome: clinical and prognostic correlation. Int J Clin Rheumtol (2012) 0.83
Autoantibodies with enzymatic properties in human autoimmune diseases. J Autoimmun (2011) 0.82
Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in Sjögren's syndrome. Arthritis Res Ther (2014) 0.82
Antibody-secreting cell specificity in labial salivary glands reflects the clinical presentation and serology in patients with Sjögren's syndrome. Arthritis Rheumatol (2014) 0.81
The immune factors involved in the pathogenesis, diagnosis, and treatment of Sjogren's syndrome. Clin Dev Immunol (2013) 0.79
Sjögren Syndrome-Associated Small Fiber Neuropathy: Characterization From a Prospective Series of 40 Cases. Medicine (Baltimore) (2013) 0.78
Autoantibodies in Sjögren's Syndrome. Rheum Dis Clin North Am (2016) 0.75
Inclusion body myositis associated with Sjögren's syndrome. Rheumatol Int (2012) 0.75
Use of a novel high-resolution magnetic resonance neurography protocol to detect abnormal dorsal root Ganglia in Sjögren patients with neuropathic pain: case series of 10 patients and review of the literature. Medicine (Baltimore) (2014) 0.75
Elevated Plasma P-Selectin Autoantibodies in Primary Sjögren Syndrome Patients with Thrombocytopenia. Med Sci Monit (2015) 0.75
Oxidative T Cell Modifications in Lupus and Sjogren's Syndrome. Lupus (Los Angel) (2017) 0.75
Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren's syndrome : A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort. Rheumatol Int (2017) 0.75
Isolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases: Results from a routine population survey. PLoS One (2017) 0.75
[Clinical spectrum of IgG4-related diseases and the connection to rheumatology]. Z Rheumatol (2016) 0.75
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68
A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum (1997) 3.62
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum (2004) 3.46
Fatal enterovirus 71 encephalomyelitis. J Pediatr (1998) 3.39
Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment. Am J Med (1997) 3.01
Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol (2001) 2.43
Validity of Euroqol--a generic health status instrument--in patients with rheumatoid arthritis. Economic and Health Outcomes Research Group. Br J Rheumatol (1994) 2.27
Behavioural problems in children who weigh 1000 g or less at birth in four countries. Lancet (2001) 2.08
A systematic review of the effectiveness of health service interventions aimed at reducing inequalities in health. J Health Serv Res Policy (1996) 2.08
Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol (1998) 2.00
Do you see what I see? Weight status misperception and exposure to obesity among children and adolescents. Int J Obes (Lond) (2008) 1.90
Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome. Arthritis Care Res (Hoboken) (2013) 1.90
High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum (2008) 1.90
Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum (2009) 1.88
Population history and its impact on medical genetics in Quebec. Clin Genet (2005) 1.85
Typical and atypical Cogan's syndrome: 32 cases and review of the literature. Rheumatology (Oxford) (2004) 1.84
Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell (1990) 1.80
Homozygous familial hypercholesterolemia among French Canadians in Québec Province. Arteriosclerosis (1989) 1.68
Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum (2002) 1.67
Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia. Acta Psychiatr Scand (2005) 1.67
Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus (1995) 1.63
[Leishmaniasis and human immunodeficiency virus infections]. Presse Med (1995) 1.61
Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study. J Pediatr (1998) 1.60
Campylobacter enteritis and erythema nodosum. Lancet (1982) 1.59
Cannabis arteritis revisited--ten new case reports. Angiology (2001) 1.58
A biochemically distinct form of cytochrome oxidase (COX) deficiency in the Saguenay-Lac-Saint-Jean region of Quebec. Am J Hum Genet (1993) 1.57
Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr Res (2001) 1.56
Refractory polymyositis responding to infliximab: extended follow-up. Rheumatology (Oxford) (2004) 1.56
Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis (2008) 1.54
Daily dosing with flutamide or Casodex exerts maximal antiandrogenic activity. Urology (1997) 1.53
Embolization of two bleeding aneurysms with platinum coils in a patient with polyarteritis nodosa. J Rheumatol (1993) 1.51
An uncommon association: celiac disease and dermatomyositis in adults. Clin Exp Rheumatol (2001) 1.49
Benefits of progestin contraception in non-allergic angioedema. Clin Exp Allergy (2013) 1.49
Neurologic crises in hereditary tyrosinemia. N Engl J Med (1990) 1.48
Thymoma-associated pancytopenia: effectiveness of cyclosporine A. Ann Hematol (1998) 1.47
Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. Arthritis Rheum (2010) 1.47
Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome. J Pediatr (1995) 1.46
Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol (2001) 1.46
Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients. Lupus (2008) 1.45
Metabolic rate, not percent dehydration, predicts rectal temperature in marathon runners. Med Sci Sports Exerc (1991) 1.45
antiphospholipid antibodies and RA: presence of beta2GP1 independent aCL. Ann Rheum Dis (2001) 1.44
Cognitive dysfunction at baseline predicts symptomatic 1-year outcome in first-episode schizophrenics. Psychopathology (2000) 1.44
STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Arthritis Rheum (2009) 1.43
Hypothenar hammer syndrome followed by systemic sclerosis. J Rheumatol (2000) 1.42
[Bordetella bronchiseptica in a patient with prostatic adenocarcinoma]. Enferm Infecc Microbiol Clin (1997) 1.41
Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J Gene Med (2001) 1.41
[Raynaud's phenomena of occupational origin]. Rev Prat (1998) 1.40
[A history of diseases: apropos of idiopathic capillary hyperpermeability syndrome]. Presse Med (1999) 1.40
Clinical, metabolic, and genetic aspects of cytochrome C oxidase deficiency in Saguenay-Lac-Saint-Jean. Am J Hum Genet (1993) 1.40
[Peripheral T-lymphocyte subpopulations in primary and alcoholic dilated cardiomyopathy]. Ann Med Interne (Paris) (1985) 1.39
Arthritis in primary antiphospholipid syndrome? J Rheumatol (1996) 1.39
[Dermatopolymyositis and chronic lymphoid leukemia. Apropos of 2 cases]. Rev Med Interne (1993) 1.39
[Testicular localization of systemic diseases]. Presse Med (1995) 1.39
[Rheumatoid hyperthyroidism. Another observation]. Presse Med (1999) 1.39
Magnetic resonance imaging in focal myositis. J Rheumatol (1998) 1.39
[Calcific arteriolopathy (Calciphylaxis)]. Rev Med Interne (2005) 1.38
Medical aspects of ketone body metabolism. Clin Invest Med (1995) 1.37
Long-term follow-up of neurosarcoidosis. Neurology (2001) 1.36
Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening program. J Pediatr (1999) 1.31
Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion. Cell Death Dis (2010) 1.31
Perioperative anaphylaxis. Med Clin North Am (2010) 1.29
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation (2002) 1.29
Non-Hodgkin malignant lymphomas and peripheral neuropathies--13 cases. Brain (1995) 1.29
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis (2008) 1.28
Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf) (2003) 1.27
Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics. Leukemia (2005) 1.27
Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore) (1999) 1.26
[Chorea and systemic lupus erythematosus with circulating anticoagulant. 3 cases]. Rev Neurol (Paris) (1985) 1.25
Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry. Arthritis Care Res (Hoboken) (2010) 1.25
Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum (2011) 1.24
Blood-cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness. J Neurol Sci (2002) 1.22
Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis (2010) 1.22
Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporter. Nat Genet (1999) 1.21
Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Ann Rheum Dis (2007) 1.21
Isolation of Campylobacter hyointestinalis from pigs in the United Kingdom. Vet Rec (1984) 1.21
Mycoplasma pneumoniae infections in a rural setting in Canada. CMAJ (1987) 1.20
Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature. Rheumatol Int (2007) 1.20
Reactive arthritis after hepatitis B vaccination. J Rheumatol (1990) 1.20
Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides. Br J Rheumatol (1997) 1.20
NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Ann Rheum Dis (2010) 1.19
Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med (2001) 1.19
Physical activity vs. sedentary time: independent associations with adiposity in children. Pediatr Obes (2012) 1.19
Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum Reprod (2001) 1.19
Genomic, protein homogeneity and antigenic variability of Mycoplasma agalactiae. Vet Microbiol (1996) 1.19
Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases. Ann Rheum Dis (2004) 1.19
Deletion proximal to DXS68 locus (L1 probe site) in a boy with Duchenne muscular dystrophy, glycerol kinase deficiency, and adrenal hypoplasia. Hum Genet (1988) 1.18
Acute myelopathies: Clinical, laboratory and outcome profiles in 79 cases. Brain (2001) 1.17